Skip to main content

Advertisement

SpringerLink
Log in

Patient awareness of smoking as a risk factor for bladder cancer

  • Urology - Original Paper
  • Published:
International Urology and Nephrology Aims and scope Submit manuscript

Abstract

Introduction

Data on general population’s and bladder cancer patients’ perception of smoking as a risk factor for bladder cancer are limited. To determine urological patients’ awareness of smoking as a risk factor for bladder cancer.

Methods

This prospective observational study included 202 consecutive urological inpatients, using a structured questionnaire. We evaluated urological patients’ awareness of smoking as a risk factor for bladder cancer and other smoking-related pathologies. Smoker-bladder cancer patients were asked whether they believed that smoking was related to their present bladder problem, whether their treating urologist had ever advised them on the same, and whether they intended to quit.

Results

Only 118 of 202 patients (58.4%) stated that they were aware of smoking as a risk factor for bladder cancer, as apposed to 94.6% for chronic obstructive pulmonary disease, 91.6% for heart and vascular problems, and 92.1%, for lung cancer. Perception was unrelated to age, gender, smoking habits, or history of heart or chronic lung disease. Of current smokers/TCC patients, 56.4% believed that smoking is related to their problem and 61.5% intended to quit. The majority (84.6%) had been already warned by their attending physicians.

Conclusions

Urological patients’ awareness of smoking as a risk factor for bladder cancer is lower than that for other smoking-related entities. The role of the urologist should not be restricted only to diagnosis and treatment, but should also include counseling patients on the need for radical changes of their life style.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Parkin DM, Bray F, Ferlay J, Pisani P (2005) Global cancer statistics, 2002. CA Cancer J Clin 55:74–108

    Article  PubMed  Google Scholar 

  2. Jemal A, Siegel R, Ward E, Murray T, Xu J, Thun MJ (2007) Cancer statistics, 2007. CA Cancer J Clin 57:43–66

    Article  PubMed  Google Scholar 

  3. Botteman MF, Pashos CL, Redaelli A, Laskin B, Hauser R (2003) The health economics of bladder cancer: a comprehensive review of the published literature. Pharmacoeconomics 21(18):1315–1330

    Article  PubMed  Google Scholar 

  4. Morrison AS, Cole P (1976) Epidemiology of bladder cancer. Urol Clin North Am 3:13–29

    CAS  PubMed  Google Scholar 

  5. Hsieh FI, Pu YS, Chern HD, Hsu LI, Chiou HY, Chen CJ (1999) Genetic polymorphisms of N-acetyltransferase and 2 and risk of cigarette smoking related bladder cancer. Br J Cancer 81:537–541

    Article  CAS  PubMed  Google Scholar 

  6. Wynder EL, Goldsmith K (1977) The epidemiology of bladder cancer. A second look. Cancer 40:1246–1268

    Article  CAS  PubMed  Google Scholar 

  7. Thompson I, Fair W (1990) Occupational and environmental factors in bladder cancer. In: Chisolm GD, Fair WR (eds) Scientific foundations of urology, 2nd edn. Heinemann Medical Books, London

    Google Scholar 

  8. Ross RK, Jones PA, Yu MC (1996) Bladder cancer epidemiology and pathogenesis. Semin Oncol 23:536–545

    CAS  PubMed  Google Scholar 

  9. Hoffmann D, Hecht SS (1990) Advances in tobacco carcinogenesis. In: Cooper CS, Grover PL (eds) Chemical carcinogenesis and mutagenesis. Springer, Berlin, pp 136–152

    Google Scholar 

  10. Bartsch H, Malaveille C, Friesen M, Kadlubar FF, Vineis P (1993) Black (air-cured) and blond (flue-cured) tobacco cancer risk. IV: molecular dosimetry studies implicate aromatic amines as bladder carcinogens. Eur J Cancer 29A(8):1199–1207

    Article  CAS  PubMed  Google Scholar 

  11. Fleshner N, Garland J, Moadel A et al (1999) Influence of smoking status on the disease-related outcomes of patients with tobacco-associated superficial transitional cell carcinoma of the bladder. Cancer 86:2337–2345

    Article  CAS  PubMed  Google Scholar 

  12. Ostroff J, Garland J, Moadel A, Fleshner N, Hay J, Cramer L et al (2000) Cigarette smoking patterns in patients after treatment of bladder cancer. J Cancer Educ 15:86–90

    CAS  PubMed  Google Scholar 

  13. Raitanen MP, Nieminen P, Tammela TL (1995) Impact of tumor grade, stage, number and size, and smoking and sex, on survival in patients with transitional cell carcinoma of the bladder. Br J Urol 76:470–474

    Article  CAS  PubMed  Google Scholar 

  14. US Department of Health and Human Service (1983) The health consequences of smoking: cardiovascular disease. A report of the surgeon general. US DHHS, Office of the Assistant Secretary of Health, Office on Smoking and Health, DHSS publication no. (PHS) 84-50204

  15. Tollerud DJ, Clark W, Brown LM et al (1989) Association of cigarette smoking with decreased numbers of circulating natural killer cells. Am Rev Resp Dis 139:194–198

    CAS  PubMed  Google Scholar 

  16. US Department of Health and Human Services (1990) The health benefits of smoking cessation. US DHHS, Public Health Service, Centers for Disease Control, Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health, DHHS Publication no. (DCD) 90-8416

  17. International Agency for Research on Cancer (2004) IARC monographs on the evaluation of the carcinogenic risks of chemicals to humans, vol 83: tobacco smoke and involuntary smoking. IARC press, Lyon, pp 1189–1312

    Google Scholar 

  18. Garcia-Closas M, Malats N, Silverman D, Dosemeci M, Kogevinas M, Hein DW et al (2005) NAT2 slow acetylation, GSTM1 null genotype, and risk of bladder cancer: results from the Spanish Bladder Cancer Study and meta-analyses. Lancet 366:649–659

    Article  CAS  PubMed  Google Scholar 

  19. Dresler CM, Leon ME, Straif K, Baan R, Secretan B (2006) Reversal of risk upon quitting smoking. Lancet 368:348–349

    Article  PubMed  Google Scholar 

  20. Strope SA, Montie JE (2008) The causal role of cigarette smoking in bladder cancer initiation and progression, and the role of urologists in smoking cessation. J Urol 180:31–37

    Article  PubMed  Google Scholar 

  21. Aveyard P, Adab P, Cheng KK, Wallace DM, Hey K, Murphy MF (2002) Does smoking status influence the prognosis of bladder cancer? A systematic review. BJU Int 90:228–239

    Article  CAS  PubMed  Google Scholar 

  22. Nieder AM, John S, Messina CR, Granek IA, Adler HL (2006) Are patients aware of the association between smoking and bladder cancer? J Urol 176:2405–2408

    Article  PubMed  Google Scholar 

  23. Breslow RA, Sorkin JD, Frey CM, Kessler LG (1997) Americans’ knowledge of cancer risk and survival. Prev Med 26:170–177

    Article  CAS  PubMed  Google Scholar 

  24. Chen C-H, Shun C-T, Huang K-H et al (2007) Stopping smoking might reduce tumour recurrence in nonmuscle-invasive bladder cancer. BJU Int 100:281–286

    Article  PubMed  Google Scholar 

  25. Dearing J (2005) Disease-centred advice for patients with superficial transitional cell carcinoma of the bladder. Ann R Coll Surg Engl 87:85–87

    Article  PubMed  Google Scholar 

  26. Vogt F, Hall S, Marteau TM (2005) General practitioners’ and family physicians’ negative beliefs and attitudes towards discussing smoking cessation with patients: a systematic review. Addiction 100:1423–1431

    Article  PubMed  Google Scholar 

  27. Bao Y, Duan N, Fox SA (2006) Is some provider advice on smoking cessation better than no advice? An instrumental variable analysis of the 2001 National Health Interview Survey. Health Serv Res 41:2114–2135

    Article  PubMed  Google Scholar 

  28. Lancaster T, Stead LF (2005) Individual behavioural counseling for smoking cessation. Cochrane Database Syst Rev 2:CD001292

    PubMed  Google Scholar 

  29. Stead LF, Lancaster T (2000) Group behaviour therapy programmes for smoking cessation. Cochrane Database Syst Rev 2:CD001007

    PubMed  Google Scholar 

  30. Moyad MA (2003) Bladder cancer prevention. Part I: what do I tell my patients about lifestyle changes and dietary supplements? Curr Opin Urol 13:363–378

    Article  PubMed  Google Scholar 

  31. Moyad MA (2003) Bladder cancer recurrence. Part II: what do I tell my patients about lifestyle changes and dietary supplements? Curr Opin Urol 13:379–383

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. 1st Department of Urology, Athens Medical School, Agiou Thoma 17, 11527, Athens, Greece

    Ioannis Anastasiou, Vasilios Mygdalis, Anastasios Mihalakis, Ioannis Adamakis, Constantinos Constantinides & Dionisios Mitropoulos

Authors
  1. Ioannis Anastasiou
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Vasilios Mygdalis
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Anastasios Mihalakis
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Ioannis Adamakis
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Constantinos Constantinides
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Dionisios Mitropoulos
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Vasilios Mygdalis.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Anastasiou, I., Mygdalis, V., Mihalakis, A. et al. Patient awareness of smoking as a risk factor for bladder cancer. Int Urol Nephrol 42, 309–314 (2010). https://doi.org/10.1007/s11255-009-9611-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11255-009-9611-4

Keywords

Search

Navigation